A panel discussion on optimising collaborative efforts in cancer research moderated by Dr Anand Jeyasekharan (left). The other panellists are (second from left) Professor Chng Wee Joo, Dr Ira Mellman and Associate Professor Daniel Tan. - Photo: ST
SINGAPORE: A national cancer consortium here has been admitted into an international expert network that will allow it to participate in global cancer trials.
For Singaporeans, it could mean access to new cancer drugs being tested, while the network will gain access to a diverse pool of Asian trial participants.
